News

The International Vision Expo East, slated for March 16 to 20 at the Jacob K. Javits Center in New York City, will include more than 55 hours of courses on managing for profitability and using technology.

A once-daily formulation of bromfenac ophthalmic solution 0.09% (Bromday, ISTA Pharmaceuticals) has been adopted quickly, so the twice-daily formulation of the (Xibrom, ISTA Pharmaceuticals) will be discontinued, according to the company.

QLT Inc. has halted a randomized, placebo-controlled, double-masked phase II proof-of-concept trial of an olopatadine (Patanol, Alcon) punctal plug delivery system (O-PPDS) after the study model ?could not generate definitive clinical results,? according to company officials.

The primary endpoint has been met in one of two phase 3 studies evaluating monthly ranibizumab injection (Lucentis, Genentech) in patients with diabetic macular edema (DME), according to the company.

"The Glaucoma Research Foundation (GRF) ?applauded those who give? at its annual benefit and celebration Jan. 26. The theme of this year?s dinner, auction, and presentations was ?Applauding Those Who Give,? and the benefit focused on recent results from GRF-funded research and the donors who made it possible. "

Transitions Optical Inc. will once again support a Spanish-language education track during International Vision Expo East, to be held March 18 to 20 at the Jacob J. Javits Center in New York City. This is the second year that Spanish-language courses will be offered to event attendees.

"A seminar designed to help investors identify opportunities and evaluate potential investment in ophthalmic research will take place in Fort Lauderdale, FL, April 29. The seminar, entitled ?Unmet Needs: Emerging Frontiers in Ophthalmic Science,? is being organized by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER). "

Refinements made to the scleral spacing procedure that uses a scleral implant and a limbal-sparing incision have improved the long-term efficacy of the procedure.

Findings from initial experiments indicate the feasibility of using femtosecond laser pulses for in situ creation of customized IOLs.

The author says that is is a source of pride and relief that, in the middle of the recession, his son recently became a gainfully employed citizen and taxpayer.

If you are not a technician, how can you survive the jungle of managing a staff of technicians? Go back to the age of dinosaurs.

There is a growing awareness that business strategies used in the fashion industry can be applied successfully in the ophthalmic market.

Results of a study applying image quality metrics already in use by the photography industry provide better understanding of the imaging properties of existing presbyopia-correcting IOLs.

The differential diagnosis of a hereditary optic neuropathy includes four possible disease categories.

Results from 6 months of follow-up in a prospective, multicenter European clinical trial show that the toric version of the foldable iris-fixated phakic IOL provides stable, effective correction of myopic astigmatism with a high safety index.

Studies in a mouse model suggest that an orally active antioxidant, N-acetylecysteine (NAC), may be beneficial in the treatment of retinitis pigmentosa.

ASCRS' annual meeting returns to San Diego this year, March 25-29.

Patients can achieve adequate uncorrected far and near vision with an increase of the depth of field with Q-adjustment and monovision.

Optimal results from surgical correction of brow ptosis depend on a thorough knowledge of available procedures and the results of each of these will have on brow shape and symmetry.

The Wilmer Eye Institute of the Johns Hopkins University School of Medicine was to hold its 28th annual Current Concepts in Ophthalmology Course on March 14-18.

Findings from a retrospective analysis including 81,715 consecutive LASIK-treated eyes provide no evidence after 12 to 24 months of follow-up that a "thin cornea" increases the risk for postoperative ectasia.

International Vision Expo East, March 16 to 20 in New York City, will showcase exhibitors from around the world and provide the opportunity to touch, learn about, and experience firsthand the many products and services available to the optical community.

The International Vision Expo East and Conference was to celebrate its 25th year, March 16 to 20, at the Jacob K. Javits Convention Center here.

Your patients may not realize that the risk for blinding eye diseases such as age-related macular degeneration (AMD) can be lessened by taking basic steps to ensure overall health. Here is some information to share with them.

The Lumbini Eye Institute and the Calabar Teaching Hospital have received $50,000 research grants from the Pediatric Cataract Initiative, a partnership of the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation that aims to prevent vision loss in children.

A team of researchers has discovered a molecular mechanism implicated in geographic atrophy that may lead to the development of ways to prevent the condition.

Sustained-release fluocinolone acetonide (Iluvien, Alimera Sciences) demonstrates statistically significant effectiveness in the treatment of diabetic macular edema (DME), according to recently released 36-month data from the FAME Study.

Attendees at the upcoming International Vision Expo and Conference can take advantage of discounted hotels and travel, as well as exclusive shopping and entertainment specials in New York City. International Vision Expo and Conference will be held March 16-20, at the Jacob K. Javits Center.